Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib

Bibliographic Details
Title: Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib
Authors: Zhou, Amy, Kong, Tim, Fowles, Jared S., Jung, Chun‐Ling, Allen, Maggie J., Fisher, Daniel A. C., Fulbright, Mary, Nemeth, Elizabeta, Ganz, Tomas, Oh, Stephen T.
Source: British journal of haematology. 197(4):e49-e52
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151815689.0x000001&indx=1&recIds=ETOCvdc_100151815689.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:00071048
Published in:British journal of haematology
Language:English